2Snmez NC,Kiremit MC,Güney S,et al.Sexual dysfunction in type III chronic prostatitis(CP)and chronic pelvic pain syndrome(CPPS)ob-served in Turkish patients(J).Int Urol Nephrol,2011;43(2):309-14.
4LeeKS,Choi JD.Chronic prostatitis:approaches for best management(J).Korean J Urol,2012;53(2):69-77.
5Tsuzaka Y,Matsushima H,Kaneko T,et al.Naftopidil vs silodosin in med-ical expulsive therapy for ureteral stones:a randomized controlled study in Japanese male patients(J).Int J Urol,2011;18(11):792-5.
6Masumori N.Naftopidil for the treatment of urinary symptoms in patients with benign prostatic hyperplasia(J).Ther Clin Risk Manag,2011;7:227-38.
7Litwin MS.A review of the development and valid&tion of the national institutes of heatth chronic prostatitis symptom index[J]. Urology,2012,60(1):14-18.
8Muller A,Mulhall JP.Sexual dysfunction in the patient with prostatitis..Current Urology Reports,2006,7(4):307-312.
9Muller A, Mulhall JP. Sexual dysfunction in the patient with prostati- tis: Current Urology Reports,2006,7 ( 4 ) :307 - 312.
10Raynaud JP,Gardette J,Rollet J,et al. Prostate-specificantigen (PSA) concentrations in hypogonadal men during6 years of transdermal testosterone treatment[J]. BJU Int,2013,111(6):880.
